| Dr David A Fox Ii, MD | |
|
2016 S Main St, Maryville, MO 64468-2655 | |
| (660) 562-2600 | |
| Not Available |
| Full Name | Dr David A Fox Ii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 2016 S Main St, Maryville, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689639619 | NPI | - | NPPES |
| P00272237 | Other | MO | RAILROAD MEDICARE |
| 202070 | Other | MO | BLUE SHIELD |
| 200311207 | Medicaid | MO | |
| 720478 | Other | HEALTHLINK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2005024752 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pershing Memorial Hospital | Brookfield, MO | Hospital |
| Wright Memorial Hospital | Trenton, MO | Hospital |
| Mercy St Francis Hospital | Mountain view, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| General John J Pershing Memorial Hospital Association | 2860306750 | 19 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | General John J Pershing Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982612461 PECOS PAC ID: 2860306750 Enrollment ID: O20031117000114 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | Mercy St Francis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023053477 PECOS PAC ID: 7810806643 Enrollment ID: O20040120000229 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | Saint Luke's Hospital Of Trenton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841274057 PECOS PAC ID: 3971495532 Enrollment ID: O20040327000339 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | Saint Lukes Hospital Of Chillicothe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245433127 PECOS PAC ID: 0143130393 Enrollment ID: O20041014000548 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | General John J Pershing Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487616256 PECOS PAC ID: 2860306750 Enrollment ID: O20050422000230 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | Mercy St Francis Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1023053477 PECOS PAC ID: 7810806643 Enrollment ID: O20061104000139 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Entity Name | Emergency Practice Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679990733 PECOS PAC ID: 6103737390 Enrollment ID: O20140506000598 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David A Fox Ii, MD 1300 N One Mile Rd, Suite 3, Dexter, MO 63841-1042 Ph: (573) 624-1640 | Dr David A Fox Ii, MD 2016 S Main St, Maryville, MO 64468-2655 Ph: (660) 562-2600 |
News Archive
Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents.
Meanwhile, in other news related to health reform, the Internal Revenue Service is seeking $119 million in new funds in order to enforce the tax-related provisions of the health overhaul.
X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets.
A fusion gene is a single composite gene that is the result of the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene has a tendency to be found in cutaneous squamous cell carcinoma (cSCC) lesions on skin exposed frequently to the sun.
› Verified 6 days ago
Dr. Sally A. Bomar, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2016 S Main St, Maryville, MO 64468 Phone: 660-562-2525 Fax: 660-562-4303 | |
Dr. Dallas Mullock, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2332 S Main St, Maryville, MO 64468 Phone: 660-562-2223 Fax: 660-562-2230 | |
Dr. Brian D. Golightly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2016 S Main St, Maryville, MO 64468 Phone: 660-562-2525 Fax: 660-562-4303 | |
Alison Sporleder, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2016 S Main St, Maryville, MO 64468 Phone: 660-562-2525 | |
Charles S Fillingane Ii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2336 S Main St Lowr Level, Maryville, MO 64468 Phone: 660-220-2123 Fax: 660-562-7911 | |
Dr. Patrick S. Dawson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2016 S Main St, Maryville, MO 64468 Phone: 660-562-2525 Fax: 660-562-7993 | |
Lisa Cox, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2016 S Main St, Maryville, MO 64468 Phone: 660-562-2600 |